Neramexane (merz pharmaceuticals/forest laboratories).

Dokumenttyp:: Journal Article
Autor(en):: Rammes, G; Schierloh, A
Titel:: Neramexane (merz pharmaceuticals/forest laboratories).
Abstract:: Merz Pharmaceuticals GmbH and Forest Laboratories Inc are developing neramexane, an oral N-methyl-D-aspartate antagonist, as a potential neuroprotectant for various central nervous system disorders, including Alzheimer's disease, and for the potential treatment of drug and alcohol dependence, and pain.
Zeitschriftentitel:: IDrugs
Jahr:: 2006
Band / Volume:: 9
Heft / Issue:: 2
Seitenangaben Beitrag:: 128-35
Sprache:: eng
PubMed:: http://view.ncbi.nlm.nih.gov/pubmed/16523403
Print-ISSN:: 1369-7056
TUM Einrichtung:: Klinik für Anästhesiologie (DHM)
BibTeX

Vorkommen: